What Buyers Asked For at Medical Fair Thailand 2023: A Field Report from QL Biotek
Medical Fair Thailand 2023 opened on 13 September and remains the largest annual gathering for the medical consumables industry in Southeast Asia. For QL Biotek, the exhibition served as a practical read on what importers, distributors and private-label buyers in the region are actually looking for in rapid diagnostic tests — and what data they ask for before signing anything.
This report summarizes the buying signals from the first days of the show and explains the product specifications behind them.
Strong first-day traffic, with clear product preferences
From day one, more than 20 buyer groups visited the QL Biotek booth, with conversations split between two distinct business models: purchasing finished test kits under agency agreements, and sourcing uncut sheets for local conversion and private labelling.
The product categories that attracted the most attention were:
- Malaria rapid detection reagents — mainly from buyers based in India and Pakistan
- Dengue fever rapid detection reagents — also drawing interest from the South Asian market
- Filarial worm (filariasis) rapid detection reagents — of interest to buyers from Hong Kong, Singapore and Malaysia
- Uncut sheets — requested by the same buyers evaluating malaria and dengue kits
Buyers from India and Pakistan showed a particular preference for uncut sheet supply, citing safety and cost-effectiveness as the main reasons they want to import the membranes directly rather than finished devices. The filariasis test requests came with a caveat: buyers from Hong Kong, Singapore and Malaysia want to confirm local import regulations before formalizing cooperation.
Why uncut sheets are gaining traction
Uncut sheets — the assembled but not-yet-cut nitrocellulose membranes carrying the full set of test and control lines — allow qualified buyers to complete cutting, assembly, packaging and labelling in their own facilities. For distributors and IVD manufacturers with local assembly capability, this model offers three practical advantages:
- Label and brand control, which matters when a buyer needs registration under their own company name
- Reduced shipping weight per unit, since bulky cassettes and foil pouches are sourced locally
- Batch-level flexibility, allowing smaller re-order quantities matched to local registration cycles
Buyers evaluating this route typically request the membrane specification, line layout, and confirmation that the sheet format matches their filling and cutting equipment before samples are shipped.
Spotlight: Malaria Pf/Pan Rapid Test Device (Whole Blood)
The malaria device attracted the most technical questions at the booth. It is a whole-blood immunoassay intended for the qualitative detection of Plasmodium falciparum and pan-malarial antigens, validated against thin or thick blood microscopy on clinical samples.
Key performance figures reported for the device:
| Parameter | Result | 95% Confidence Interval |
|---|---|---|
| Relative sensitivity (Pan) | >99.9% (103/103) | 96.5% – 100.0% |
| Relative sensitivity (P.f) | >99.9% (53/53) | 93.3% – 100.0% |
| Relative specificity | 99.1% (213/215) | 96.7% – 99.9% |
| Accuracy | 99.4% (359/361) | 98.0% – 99.9% |
The test relies on highly specific antibodies against malaria antigens in whole blood. For importers, the point that generated the most interest is the sample format: whole blood collection keeps the workflow compatible with point-of-use settings where microscopy is unavailable or impractical.
What buyers asked before requesting samples
Across all product categories, conversations followed a similar pattern. Before committing to samples or agency discussions, buyers focused on three checkpoints:
- Registration fit — whether the test is registered, or registrable, in the target market, and which documents support the filing
- Format compatibility — device format, sheet layout, packaging configuration and shelf-life documentation
- Supply structure — finished kits versus uncut sheets, and how private-label orders are handled
Regional buyers approached these questions differently. South Asian buyers leaned toward direct import of uncut sheets, while buyers from Hong Kong, Singapore and Malaysia wanted regulatory clearance confirmed first, then a cooperation framework.
Practical takeaway for distributors
The signals from Medical Fair Thailand 2023 point to a market that is moving beyond commodity purchasing. Distributors are asking for validation data in a structured form, formats they can localise, and a clear answer on registration support. Agencies that arrive at a first meeting with their market's import requirements in hand tend to move faster from sample request to repeat order.
QL Biotek supplies rapid test kits and uncut sheets across infectious disease, fertility, cardiac marker, tumour, drug of abuse and animal health categories, with technical documentation prepared for distributor review.
FAQ
1. What is an uncut sheet, and who is it suitable for?
An uncut sheet is a processed nitrocellulose membrane containing all test and control lines before it is cut into individual strips. It is intended for buyers with their own cutting, assembly and packaging capacity who want to control branding, labelling and local registration.
2. How is the Malaria Pf/Pan Rapid Test Device validated?
Clinical samples were tested using thin or thick blood microscopy as the reference method. The reported results show relative sensitivity above 99.9% for both Pan and P.f targets, relative specificity of 99.1%, and overall accuracy of 99.4%, with 95% confidence intervals as listed above.
3. What should a buyer prepare before requesting samples?
Have your local import and registration requirements ready, confirm whether you need finished devices or uncut sheets, and specify the target product categories. This allows documentation and format questions to be resolved before the sample stage.